US Stock MarketDetailed Quotes

Caribou Biosciences (CRBU)

Watchlist
  • 1.520
  • -0.040-2.56%
Trading Jan 16 12:06 ET
142.07MMarket Cap-0.89P/E (TTM)

Caribou Biosciences (CRBU) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
8.60%2.2M
-23.01%2.67M
-3.13%2.35M
-71.01%9.99M
-41.62%2.08M
-91.45%2.02M
-7.75%3.46M
-30.64%2.43M
148.91%34.48M
-3.63%3.56M
Operating revenue
8.60%2.2M
-23.01%2.67M
-3.13%2.35M
-71.01%9.99M
-41.62%2.08M
-91.45%2.02M
-7.75%3.46M
-30.64%2.43M
148.91%34.48M
-3.63%3.56M
Cost of revenue
Gross profit
Operating expense
-21.52%31.6M
-18.89%38.1M
-6.54%45.27M
17.32%176.61M
-0.12%40.95M
5.14%40.26M
28.24%46.97M
39.90%48.43M
25.19%150.54M
19.64%41M
Selling and administrative expenses
-6.54%9.2M
-9.42%10.4M
-33.52%9.74M
20.79%46.46M
7.89%10.49M
1.34%9.84M
13.49%11.49M
64.36%14.64M
1.16%38.46M
13.91%9.72M
-General and administrative expense
-6.54%9.2M
-9.42%10.4M
-33.52%9.74M
20.79%46.46M
7.89%10.49M
1.34%9.84M
13.49%11.49M
64.36%14.64M
1.16%38.46M
13.91%9.72M
Research and development costs
-26.36%22.4M
-21.95%27.69M
5.16%35.53M
16.13%130.15M
-2.61%30.46M
6.43%30.42M
33.87%35.48M
31.42%33.79M
36.29%112.08M
21.54%31.28M
Operating profit
23.11%-29.4M
18.56%-35.43M
6.71%-42.91M
-43.56%-166.62M
-3.83%-38.88M
-161.31%-38.24M
-32.35%-43.5M
-47.84%-46M
-9.08%-116.06M
-22.45%-37.44M
Net non-operating interest income expense
Other net income (expense)
-47.89%1.85M
-421.67%-18.67M
-38.72%2.92M
23.41%17.5M
7.86%3.38M
-23.26%3.55M
73.31%5.8M
55.21%4.77M
101.22%14.18M
-14.46%3.13M
Gain on sale of security
----
----
----
----
----
-250.00%-14K
-563.64%-102K
----
----
----
Special income (charges)
--0
---21.31M
----
----
----
--0
--0
----
----
----
-Write off
--0
--21.31M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
-47.89%1.85M
-54.55%2.64M
-38.72%2.92M
23.41%17.5M
7.76%3.38M
-23.32%3.55M
74.45%5.8M
54.45%4.77M
97.49%14.18M
-15.76%3.13M
Income before tax
20.57%-27.55M
-43.51%-54.1M
3.01%-39.99M
-46.37%-149.11M
-3.46%-35.5M
-246.77%-34.68M
-27.70%-37.7M
-47.03%-41.23M
-2.54%-101.88M
-27.46%-34.31M
Income tax
-104.66%-9K
175.71%193K
Net income
20.57%-27.55M
-43.51%-54.1M
3.01%-39.99M
-46.08%-149.11M
-2.85%-35.49M
-246.77%-34.68M
-27.70%-37.7M
-47.03%-41.23M
-2.66%-102.07M
-27.85%-34.51M
Net income continuous Operations
20.57%-27.55M
-43.51%-54.1M
3.01%-39.99M
-46.08%-149.11M
-2.85%-35.49M
-246.77%-34.68M
-27.70%-37.7M
-47.03%-41.23M
-2.66%-102.07M
-27.85%-34.51M
Minority interest income
Net income attributable to the parent company
20.57%-27.55M
-43.51%-54.1M
3.01%-39.99M
-46.08%-149.11M
-2.85%-35.49M
-246.77%-34.68M
-27.70%-37.7M
-47.03%-41.23M
-2.66%-102.07M
-27.85%-34.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.57%-27.55M
-43.51%-54.1M
3.01%-39.99M
-46.08%-149.11M
-2.85%-35.49M
-246.77%-34.68M
-27.70%-37.7M
-47.03%-41.23M
-2.66%-102.07M
-27.85%-34.51M
Basic earnings per share
21.05%-0.3
-38.10%-0.58
6.52%-0.43
-19.57%-1.65
2.50%-0.39
-216.67%-0.38
12.50%-0.42
0.00%-0.46
15.85%-1.38
9.09%-0.4
Diluted earnings per share
21.05%-0.3
-38.10%-0.58
6.52%-0.43
-19.57%-1.65
2.50%-0.39
-216.67%-0.38
12.50%-0.42
0.00%-0.46
15.85%-1.38
9.09%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 8.60%2.2M-23.01%2.67M-3.13%2.35M-71.01%9.99M-41.62%2.08M-91.45%2.02M-7.75%3.46M-30.64%2.43M148.91%34.48M-3.63%3.56M
Operating revenue 8.60%2.2M-23.01%2.67M-3.13%2.35M-71.01%9.99M-41.62%2.08M-91.45%2.02M-7.75%3.46M-30.64%2.43M148.91%34.48M-3.63%3.56M
Cost of revenue
Gross profit
Operating expense -21.52%31.6M-18.89%38.1M-6.54%45.27M17.32%176.61M-0.12%40.95M5.14%40.26M28.24%46.97M39.90%48.43M25.19%150.54M19.64%41M
Selling and administrative expenses -6.54%9.2M-9.42%10.4M-33.52%9.74M20.79%46.46M7.89%10.49M1.34%9.84M13.49%11.49M64.36%14.64M1.16%38.46M13.91%9.72M
-General and administrative expense -6.54%9.2M-9.42%10.4M-33.52%9.74M20.79%46.46M7.89%10.49M1.34%9.84M13.49%11.49M64.36%14.64M1.16%38.46M13.91%9.72M
Research and development costs -26.36%22.4M-21.95%27.69M5.16%35.53M16.13%130.15M-2.61%30.46M6.43%30.42M33.87%35.48M31.42%33.79M36.29%112.08M21.54%31.28M
Operating profit 23.11%-29.4M18.56%-35.43M6.71%-42.91M-43.56%-166.62M-3.83%-38.88M-161.31%-38.24M-32.35%-43.5M-47.84%-46M-9.08%-116.06M-22.45%-37.44M
Net non-operating interest income expense
Other net income (expense) -47.89%1.85M-421.67%-18.67M-38.72%2.92M23.41%17.5M7.86%3.38M-23.26%3.55M73.31%5.8M55.21%4.77M101.22%14.18M-14.46%3.13M
Gain on sale of security ---------------------250.00%-14K-563.64%-102K------------
Special income (charges) --0---21.31M--------------0--0------------
-Write off --0--21.31M--------------0--0------------
Other non- operating income (expenses) -47.89%1.85M-54.55%2.64M-38.72%2.92M23.41%17.5M7.76%3.38M-23.32%3.55M74.45%5.8M54.45%4.77M97.49%14.18M-15.76%3.13M
Income before tax 20.57%-27.55M-43.51%-54.1M3.01%-39.99M-46.37%-149.11M-3.46%-35.5M-246.77%-34.68M-27.70%-37.7M-47.03%-41.23M-2.54%-101.88M-27.46%-34.31M
Income tax -104.66%-9K175.71%193K
Net income 20.57%-27.55M-43.51%-54.1M3.01%-39.99M-46.08%-149.11M-2.85%-35.49M-246.77%-34.68M-27.70%-37.7M-47.03%-41.23M-2.66%-102.07M-27.85%-34.51M
Net income continuous Operations 20.57%-27.55M-43.51%-54.1M3.01%-39.99M-46.08%-149.11M-2.85%-35.49M-246.77%-34.68M-27.70%-37.7M-47.03%-41.23M-2.66%-102.07M-27.85%-34.51M
Minority interest income
Net income attributable to the parent company 20.57%-27.55M-43.51%-54.1M3.01%-39.99M-46.08%-149.11M-2.85%-35.49M-246.77%-34.68M-27.70%-37.7M-47.03%-41.23M-2.66%-102.07M-27.85%-34.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.57%-27.55M-43.51%-54.1M3.01%-39.99M-46.08%-149.11M-2.85%-35.49M-246.77%-34.68M-27.70%-37.7M-47.03%-41.23M-2.66%-102.07M-27.85%-34.51M
Basic earnings per share 21.05%-0.3-38.10%-0.586.52%-0.43-19.57%-1.652.50%-0.39-216.67%-0.3812.50%-0.420.00%-0.4615.85%-1.389.09%-0.4
Diluted earnings per share 21.05%-0.3-38.10%-0.586.52%-0.43-19.57%-1.652.50%-0.39-216.67%-0.3812.50%-0.420.00%-0.4615.85%-1.389.09%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More